Half-and-half nails in a patient on antituberculosis treatment.
Adult Intensive Care Unit, Oxford University NHS Trust, Oxford, UK.
Andrew
A
Chadwick
Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, UK.
Victoria
V
Thwaites
Respiratory Department, Stoke Mandeville Hospital, Aylesbury, Buckinghamshire, UK.
Margaret
M
Holland
Department of Respiratory Medicine, Stoke Mandeville Hospital, Aylesbury, UK.
Mitra
M
Shahidi
D000995:Antitubercular Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects*; D055985:Latent Tuberculosis / Q000188:drug therapy*; D009260:Nail Diseases / Q000139:chemically induced*; D055815:Young Adult
D000995:Antitubercular Agents; D007538:Isoniazid